Literature DB >> 1107450

Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.

M S Simberkoff, I Ricupero, J J Rahal.   

Abstract

Serratia marcescens strains isolated from clinical specimens can be divided into those which are sensitive or resistant to the bactericidal activity of normal human serum. Serum bactericidal activity is heat labile, cation dependent, and is absorbable by whole, serum-sensitive Serratia or ethanol-insoluble extracts of these organisms. Bacteremic Serratia infection is invariably caused by the serum-resistant strains. Serum resistant Serratia are ingested and killed by normal human leukocytes and fresh normal serum. Heating or preabsorption of serum with whole, heat-killed, or ethanol-insoluble antigen extracts of the serum-resistant Serratia diminishes opsonization and phagocytosis. Serratia opsonins in the serum of healthy individuals are type-specific IgM globulins which combine with the organism and activate complement by the alternate pathway.

Entities:  

Mesh:

Year:  1976        PMID: 1107450

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  15 in total

1.  Evidence for quantitative variability of bacterial opsonic requirements.

Authors:  J C Guckian; W D Christensen; D P Fine
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Immunophysical characterization of human isolates of Serratia marcescens.

Authors:  R M Hamadeh; R E Mandrell; J M Griffiss
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

3.  Killing of an encapsulated strain of Escherichia coli by human serum.

Authors:  P W Taylor; H P Kroll
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

Review 4.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

5.  Lysozyme: primary bactericidin in human plasma serum active against Bacillus subtilis.

Authors:  M E Selsted; R J Martinez
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

Review 6.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

7.  Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  H Sahly; H Aucken; V J Benedí; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; J M Tomás; D Sandvang; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Deficiency of serum bactericidal activity against Salmonella typhimurium in sickle cell anaemia.

Authors:  W L Hand; N L King
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

9.  Plasmid carriage and the serum sensitivity of enterobacteria.

Authors:  P W Taylor; C Hughes
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  Virulence factors of Haemophilus ducreyi.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.